In August, a ruling rejecting the use of a prostate cancer drug in the United Kingdom was deemed a ‘fiasco’. Why was this and what are the ramifications of this for treatment of this cancer? Dr. George Lee is accompanied by Dr. Rachael Khong, clinical oncologist, in examining this issue.